Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncogene

Showing results (151-160 of 22,545) with videos related to

Pageof 2,255
Sort By:
Oncogene|July 28, 2010
The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cellsN Goncharenko-Khaider, D Lane, I Matte, et al.
Oncogene|May 18, 2010
Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53T Fishler, Y-Y Li, R-H Wang, et al.
Oncogene|June 10, 2010
Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cellsS-H Lee, G-N Shen, Y S Jung, et al.
Oncogene|June 10, 2010
A mosaic mouse model of astrocytoma identifies alphavbeta8 integrin as a negative regulator of tumor angiogenesisJ H Tchaicha, A K Mobley, M G Hossain, et al.
Oncogene|June 10, 2010
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expressionD Gkika, M Flourakis, L Lemonnier, et al.
Oncogene|June 10, 2010
The NADPH oxidases NOX4 and DUOX2 regulate cell cycle entry via a p53-dependent pathwayA Salmeen, B O Park, T Meyer
Oncogene|August 31, 2010
Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repairL Tian, G Peng, J M Parant, et al.
Oncogene|August 31, 2010
The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cellsJ Dhillon, A Astanehe, C Lee, et al.
Oncogene|August 31, 2010
Inhibition of β1 integrin and IL-3Rβ common subunit interaction hinders tumour angiogenesisB Uberti, P Dentelli, A Rosso, et al.
Oncogene|August 31, 2010
PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapyE Salvati, M Scarsella, M Porru, et al.
Pageof 2,255

Showing results (151-160 of 22,545) with videos related to

Sort By:
Pageof 2,255
Oncogene|July 28, 2010
The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cellsN Goncharenko-Khaider, D Lane, I Matte, et al.
Oncogene|May 18, 2010
Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53T Fishler, Y-Y Li, R-H Wang, et al.
Oncogene|June 10, 2010
Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cellsS-H Lee, G-N Shen, Y S Jung, et al.
Oncogene|June 10, 2010
A mosaic mouse model of astrocytoma identifies alphavbeta8 integrin as a negative regulator of tumor angiogenesisJ H Tchaicha, A K Mobley, M G Hossain, et al.
Oncogene|June 10, 2010
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expressionD Gkika, M Flourakis, L Lemonnier, et al.
Oncogene|June 10, 2010
The NADPH oxidases NOX4 and DUOX2 regulate cell cycle entry via a p53-dependent pathwayA Salmeen, B O Park, T Meyer
Oncogene|August 31, 2010
Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repairL Tian, G Peng, J M Parant, et al.
Oncogene|August 31, 2010
The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cellsJ Dhillon, A Astanehe, C Lee, et al.
Oncogene|August 31, 2010
Inhibition of β1 integrin and IL-3Rβ common subunit interaction hinders tumour angiogenesisB Uberti, P Dentelli, A Rosso, et al.
Oncogene|August 31, 2010
PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapyE Salvati, M Scarsella, M Porru, et al.
Pageof 2,255